!
!
Sign in / Join ICS
Home
A combination therapy with low dose desmopressin and tolterodine improves health-related quality of life in female patients with overactive bladder and nocturnal polyuria
Andersson F
1
, Raymond K
1
, Vinter Juul K
1
, Rosen R
2
Research Type
Clinical
Abstract Category
Nocturia
Abstract 35
Nocturia/Male LUTS
Scientific Podium Short Oral Session 5
Wednesday 7th October 2015
11:00 - 11:07
210BC
Nocturia
Quality of Life (QoL)
Questionnaire
Female
Clinical Trial
1.
Ferring Pharmaceuticals, Kay Fiskers Plads 11 Copenhagen S, Denmark,
2.
New England Research Institutes, Inc., Watertown, MA, USA
Presenter
K
Kristian Vinter Juul
Links
Abstract PDF
Disclosure PDF
Edit Abstract
Abstract Centre
Abstract
12/07/2024 07:27:14